Literature DB >> 14767541

Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.

Norio Iizuka1, Masaaki Oka, Hisafumi Yamada-Okabe, Kenji Hamada, Hironobu Nakayama, Naohide Mori, Takao Tamesa, Toshimasa Okada, Norikazu Takemoto, Katsuhiro Matoba, Motonari Takashima, Katsuhiko Sakamoto, Akira Tangoku, Takanobu Miyamoto, Shunji Uchimura, Yoshihiko Hamamoto.   

Abstract

Chronic infection with hepatitis B or C virus (HBV or HCV) is the most clearly established risk factor for hepato-cellular carcinoma (HCC). One type of HCC (non-B, non-C HCC) also appears to develop in patients negative for both HBV and HCV. Using a supervised learning method, we investigated gene expression in 11 non-B, non-C HCCs with high-density oligonucleotide microarrays, and compared the patterns of gene expression with those of HBV-infected HCCs (B-type HCCs) and HCV-infected HCCs (C-type HCCs) in the previous dataset. Our gene selection identified 112 and 64 genes that were differentially expressed in non-B, non-C HCC in comparison with B- and C-type HCCs, respectively. In both gene selections, we found that the false discovery rate, the percentage of genes identified by chance, was less than 5%. Additionally, in combination with the previous data, our present data revealed a set of genes specific to each type of B- and C-type HCCs and non-B, non-C HCC. Among these, an interferon-induced gene, IFI27, was differentially expressed among all three types of HCCs, and this result was confirmed by RT-PCR. Thus, our present study provides a framework to characterize the molecular features in the three subtypes of HCC with different viral origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14767541

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.

Authors:  Ludwig Wilkens; Rolf Jaggi; Caroline Hammer; Daniel Inderbitzin; Olivier Giger; Nils von Neuhoff
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

2.  Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis.

Authors:  Michele Barone; Daniela Spano; Maria D'Apolito; Marta Centra; Carla Lasalandra; Mario Capasso; Alfredo Di Leo; Stefano Volinia; Diego Arcelli; Natalia Rosso; Antonio Francavilla; Claudio Tiribelli; Achille Iolascon
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

3.  Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Bridgette Williams; Robert A Fisher
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

Review 4.  Hepatitis C virus infection--pathobiology and implications for new therapeutic options.

Authors:  Gary L Davis; Kris Krawczynski; Gyongyi Szabo
Journal:  Dig Dis Sci       Date:  2007-02-27       Impact factor: 3.199

5.  Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury.

Authors:  Lauren M Aleksunes; Michael Goedken; José E Manautou
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

6.  Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence.

Authors:  Frederique Caillot; Celine Derambure; Paulette Bioulac-Sage; Arnaud Francois; Michel Scotte; Odile Goria; Martine Hiron; Maryvonne Daveau; Jean Philippe Salier
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  The hepatic transcriptome in human liver disease.

Authors:  Nicholas A Shackel; Devanshi Seth; Paul S Haber; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Comp Hepatol       Date:  2006-11-07

8.  Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.

Authors:  Xiaonan Zhao; Zhenzi Bai; Chenghua Li; Chuanlun Sheng; Hongyan Li
Journal:  Biomed Res Int       Date:  2020-04-14       Impact factor: 3.411

9.  Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma.

Authors:  Amna Subhan Butt; Saeed Hamid; Ashfaq Ahmad Wadalawala; Mariam Ghufran; Ammar Asrar Javed; Omer Farooq; Bilal Ahmed; Tanveer Ul Haq; Wasim Jafri
Journal:  BMC Res Notes       Date:  2013-04-08

10.  Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease.

Authors:  Chansik An; Youn Ah Choi; Dongil Choi; Yong Han Paik; Sang Hoon Ahn; Myeong-Jin Kim; Seung Woon Paik; Kwang-Hyub Han; Mi-Suk Park
Journal:  Clin Mol Hepatol       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.